Many therapeutic agents have been advocated for use in cats with idiopathic lower urinary tract disease (iLUTD); however, few have been subject to controlled clinical trials proving their efficacy and safety. The problem is compounded by the fact that clinical signs associated with iLUTD are frequently of short duration and self-limiting. Consequently, any form of therapy may appear beneficial as long as it is not harmful. This article explores various options for managing clinical signs and potential sequelae associated with iLUTD.
|Original language||English (US)|
|Number of pages||13|
|Journal||Compendium on Continuing Education for the Practicing Veterinarian|
|State||Published - Jun 1 1999|